DD295087A5 - Pharmazeutische zusammensetzung und verfahren zu deren herstellung - Google Patents

Pharmazeutische zusammensetzung und verfahren zu deren herstellung Download PDF

Info

Publication number
DD295087A5
DD295087A5 DD90341641A DD34164190A DD295087A5 DD 295087 A5 DD295087 A5 DD 295087A5 DD 90341641 A DD90341641 A DD 90341641A DD 34164190 A DD34164190 A DD 34164190A DD 295087 A5 DD295087 A5 DD 295087A5
Authority
DD
German Democratic Republic
Prior art keywords
freeze
dried
solution
temperature
composition
Prior art date
Application number
DD90341641A
Other languages
German (de)
English (en)
Inventor
Bruce E Haeger
James R Lawter
Vijay H Naringrekar
Michael C Cucolo
Original Assignee
������@������@��������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23442747&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD295087(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ������@������@��������@���Kk�� filed Critical ������@������@��������@���Kk��
Publication of DD295087A5 publication Critical patent/DD295087A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DD90341641A 1989-06-14 1990-06-14 Pharmazeutische zusammensetzung und verfahren zu deren herstellung DD295087A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/366,374 US5059619A (en) 1989-06-14 1989-06-14 Stable freeze-dried polyhematoporphyrin ether/ester

Publications (1)

Publication Number Publication Date
DD295087A5 true DD295087A5 (de) 1991-10-24

Family

ID=23442747

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90341641A DD295087A5 (de) 1989-06-14 1990-06-14 Pharmazeutische zusammensetzung und verfahren zu deren herstellung

Country Status (26)

Country Link
US (1) US5059619A (cs)
EP (1) EP0402637B1 (cs)
JP (1) JP3112918B2 (cs)
KR (1) KR0164845B1 (cs)
CN (1) CN1058388C (cs)
AR (1) AR244549A1 (cs)
AT (1) ATE144703T1 (cs)
AU (1) AU625549B2 (cs)
CA (1) CA2018751C (cs)
CZ (1) CZ283309B6 (cs)
DD (1) DD295087A5 (cs)
DE (1) DE69029012T2 (cs)
DK (1) DK0402637T3 (cs)
ES (1) ES2095846T3 (cs)
FI (1) FI101597B (cs)
GR (1) GR3021511T3 (cs)
HU (1) HU215522B (cs)
IE (1) IE902137A1 (cs)
IL (1) IL94448A (cs)
NO (1) NO176645C (cs)
NZ (1) NZ233953A (cs)
PL (1) PL164744B1 (cs)
PT (1) PT94344B (cs)
RU (1) RU2019990C1 (cs)
TW (1) TW225475B (cs)
ZA (1) ZA904599B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
US5244914A (en) * 1992-04-27 1993-09-14 American Cyanamid Company Stable porfimer sodium compositions and methods for their manufacture
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5660181A (en) * 1994-12-12 1997-08-26 Physical Optics Corporation Hybrid neural network and multiple fiber probe for in-depth 3-D mapping
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
US5958104A (en) * 1997-09-11 1999-09-28 Nonomura; Arthur M. Methods and compositions for enhancing plant growth
CA2221912A1 (en) * 1997-11-21 1999-05-21 David Dolphin Photosensitizers with improved biodistribution and light-absorbing properties
HU229805B1 (en) 2000-11-29 2014-07-28 Pci Biotech As Photochemical internalization for delivery of molecules into the cytosol
EP1339862B1 (en) 2000-11-29 2014-01-08 PCI Biotech AS Photochemical internalization for virus-mediated molecule delivery into the cytosol
US7175611B2 (en) 2002-06-05 2007-02-13 Mark Alan Mitchnick Antimicrobial release system
RU2223963C1 (ru) * 2002-06-25 2004-02-20 Московская государственная академия тонкой химической технологии им. М.В. Ломоносова Способ получения производного гематопорфирина
CN103961323B (zh) * 2013-02-05 2017-10-17 浙江海正药业股份有限公司 一种注射用hpph冻干粉针制剂及其制备方法
US9733187B2 (en) * 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2858320A (en) * 1956-04-02 1958-10-28 Baxter Laboratories Inc Stable hematoporphyrin
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
AU589957B2 (en) * 1985-04-30 1989-10-26 Nippon Petrochemicals Company Limited New tetrapyrrole therapeutic agents
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy

Also Published As

Publication number Publication date
ATE144703T1 (de) 1996-11-15
CZ283309B6 (cs) 1998-02-18
KR910000146A (ko) 1991-01-29
NO176645B (no) 1995-01-30
DK0402637T3 (da) 1997-04-07
HUT54888A (en) 1991-04-29
CA2018751C (en) 2001-08-21
DE69029012T2 (de) 1997-02-27
IL94448A (en) 1994-06-24
CA2018751A1 (en) 1990-12-14
PT94344B (pt) 1997-04-30
FI101597B1 (fi) 1998-07-31
TW225475B (cs) 1994-06-21
CN1047973A (zh) 1990-12-26
EP0402637B1 (en) 1996-10-30
DE69029012D1 (de) 1996-12-05
IL94448A0 (en) 1991-03-10
GR3021511T3 (en) 1997-01-31
CS9002889A2 (en) 1991-11-12
AU5708990A (en) 1990-12-20
AU625549B2 (en) 1992-07-16
NO902634D0 (no) 1990-06-13
AR244549A1 (es) 1993-11-30
CN1058388C (zh) 2000-11-15
FI101597B (fi) 1998-07-31
KR0164845B1 (ko) 1999-01-15
HU903850D0 (en) 1990-11-28
JPH0331283A (ja) 1991-02-12
US5059619A (en) 1991-10-22
EP0402637A2 (en) 1990-12-19
EP0402637A3 (en) 1991-04-03
IE902137L (en) 1990-12-14
RU2019990C1 (ru) 1994-09-30
NO176645C (no) 1995-05-10
IE902137A1 (en) 1991-01-02
PT94344A (pt) 1991-02-08
FI902966A0 (fi) 1990-06-13
ES2095846T3 (es) 1997-03-01
ZA904599B (en) 1991-04-24
NZ233953A (en) 1992-08-26
JP3112918B2 (ja) 2000-11-27
NO902634L (no) 1990-12-17
HU215522B (hu) 1999-01-28
PL164744B1 (pl) 1994-10-31

Similar Documents

Publication Publication Date Title
DE69624485T2 (de) Verfahren zur herstellung hydro-monobenzoporhyrin -photosensibilisatoren enthaltender liposomen
DE69822496T2 (de) Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen
DE69309340T2 (de) Stabile Natrium-Porfimerzusammensetzungen und Verfahren zu ihrer Herstellung
EP1455824B1 (de) Lyophilisierte zubereitung enthaltend antikörper gegen den egf-rezeptor
EP1687031B1 (de) Pharmazeutische zubereitung enthaltend einen antikörper gegen den rezeptor für einen epidermalen wachstumsfaktor (egf-rezeptor)
DE69029012T2 (de) Stabile und lyophilisierte Zusammensetzung von Polyhematoporphyrinester oder -äther
EP2865391B1 (de) Verfahren zur Herstellung einer gefriergetrockneten pharmazeutischen Zusammensetzung mit Gehalt an Mitomycin C
EP0392429A1 (de) Psoralen-Reagens
EP0722719B1 (de) Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen
EP1750700B1 (de) Flüssige zubereitung für die veterinärmedizin; verfahren zu deren herstellung und deren verwendung
EP1406658A1 (de) Flüssige formulierung enthaltend cetuximab und einen polyoxyethylensorbitan-fettsäureester
EP1021198B1 (de) Flavonolignan-zubereitungen, insbesondere silymarin-zubereitungen
EP2142169B1 (de) Wässrige pharmazeutische zubereitung
DE69433055T2 (de) Zusammensetzung zum heilen von verletztem gewebe, verfahren für ihre herstellung und ihre verwendung
EP3820524B1 (de) Hypericin-pvp komplex mit hohem hypericinanteil
DE69000268T2 (de) Stabilisiertes antitumormittel.
EP3558262B1 (de) Hsa-galenik
WO2006119994A2 (de) Verfahren zur herstellung von albumin-konjugaten mit einem röntgenkontrastmittel als wirkstoff
DD272033A1 (de) Verfahren zur herstellung eines arzneimittels zur photochemotherapeutischen behandlung von tumoren der harnblase

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20100615